Literature DB >> 16277028

Relationship of nm23 expression to proliferation and prognosis in malignant melanomas of the oral cavity.

Monika Korabiowska1, Johannes F Hönig, Jacek Jawien, Jadwiga Knapik, Jerzy Stachura, Carlos Cordon-Cardo, Gösta Fischer.   

Abstract

Twenty-nine cases of oral melanomas were investigated for nm23 and Ki67 antigen expression, as well as for the fraction of tumour cells in S-phase, using immunohistochemical techniques and DNA cytophotometry. Nm23 expression was significantly reduced and Ki67 antigen expression increased in primary tumours with either lymph node or organ metastases in comparison to tumours without metastases. The percentages of Ki67 immunoreactive tumour cells and cells in S-phase correlated positively with each other and negatively with the percentage of nm23-expressing cells. These data argue against a significant growth stimulatory function of the nm23H1 gene product nucleoside diphopshate kinase in the progression of oral melanomas. The functional relevance of nm23 in relation to increased proliferation and metastatic spread is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16277028

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

1.  Relationship between nm23H1 genetic instability and clinical pathological characteristics in Chinese digestive system cancer patients.

Authors:  Yue-Qin Yang; Liang Wu; Jin-Xing Chen; Jian-Zhong Sun; Meng Li; Dong-Mei Li; Hai-Ying Lu; Zhi-Hong Su; Xin-Qiu Lin; Ji-Cheng Li
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

2.  NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.

Authors:  Choon-Yee Tan; Christina L Chang
Journal:  Lab Invest       Date:  2017-10-09       Impact factor: 5.662

3.  nm23H1 expression and its role in the evolution of non-gastrointestinal malignancies.

Authors:  Shailendra Kapoor
Journal:  World J Gastroenterol       Date:  2009-01-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.